Roche Carolina Inc. to Expand Manufacturing at Florence Facility
Published: Apr 25, 2007
FLORENCE, S.C., April 25 /PRNewswire/ -- Roche Carolina Inc. (RCI) announced today an expansion of its Florence pharmaceutical manufacturing facility. The $60 million investment will involve the construction of a new multi-purpose production unit in an existing manufacturing building. The expansion will help enable Roche to meet production needs for current and future life-saving medications. As a result of this investment, 25 to 30 new positions are expected to be created at the facility.
Construction is scheduled to begin in mid 2007 with completion by the end of 2008. An estimated 200 construction related jobs, many to be provided through local contractors, will be required for the project.
"The decision to invest in Florence is a reflection of our past success and the willingness of Florence and South Carolina to encourage the growth of existing industry," said Dr. Frank Cox, President and General Manager of Roche Carolina Inc. "We are grateful to the community for its support and recognition of the underlying importance of our business to improving human health."
"It speaks well about the workforce, community and the local government anytime we have an existing industry expand in Florence County," said Joe W. King, Executive Director, Florence County Economic Development Partnership. "As a major player in the worldwide pharmaceutical industry, we are excited Roche has chosen to expand their roots in our region. Roche has been a great corporate citizen over the last fifteen years; they consistently assist us in the recruiting of new industries to the area by selling the Florence community as a great place to do business."
Roche Carolina Inc., a pharmaceutical process development and bulk active ingredient manufacturing company, is an affiliate of the multinational group of companies headed by Roche Holding Ltd. of Basel, Switzerland.
Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2006, Roche was named one of the Top 20 Employers (Science magazine), ranked the No. 1 Company to Sell For (Selling Power), and one of AARP's Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine's Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or www.roche.us.
All trademarks used or mentioned in this release are protected by law.Roche Carolina Inc.
CONTACT: Public Affairs of Roche Carolina Inc., +1-973-562-2699
Web site: http://www.rocheusa.com/